The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

NCT04694183 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Camrelizumab
DRUG: S-1
DRUG: Oxaliplatin
DRUG: Paclitaxel

Sponsor

Quan Wang